Millipore Sigma Vibrant Logo

SCC291 SHSY-5Y Tet-On Inducible Alpha-Synuclein Neuroblastoma Cell Line

SHSY-5Y Tet-ON inducible α-synuclein neuroblastoma cell line serves as a model for both dopaminergic neuronal biology and α-synuclein pathology.

View Products on Sigmaaldrich.com
SCC291
≥1X10⁶ cells/vial   
Retrieving price...
Price could not be retrieved
Minimum Quantity is a multiple of
Maximum Quantity is
Upon Order Completion More Information
You Saved ()
 
—
Request Pricing
—
Fulfillment and Delivery Delayed Fulfillment and Delivery Delayed
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

       

      Contact Customer Service

      Overview

      Replacement Information
      Description
      Catalogue NumberSCC291
      DescriptionSHSY-5Y Tet-On Inducible Alpha-Synuclein Neuroblastoma Cell Line
      OverviewThe SHSY-5Y Tet-ON inducible α-synuclein neuroblastoma cell line serves as a model for both dopaminergic neuronal biology and α-synuclein pathology. SHSY-5Y cells may be induced upon treatment with retinoic acid to differentiate into neuronal-type cells, enabling studies of neuronal function and differentiation.4 SHSY-5Y cells secrete catecholamines and thus serve as a model for dopaminergic neurons. The SHSY-5Y TetON α-synuclein inducible cell line harbors an α-synuclein construct inducible by treatment with doxycycline, thus allowing controlled overexpression of α-synuclein before or after neuronal differentiation.5 The construct also includes a tet repressor, which prevents leaky expression in absence of inducer. This unique cell line is an excellent model for both the basic cellular physiology of Parkinson’s disease and therapeutic development.
      Alternate Names
      • SH-SY5Y Tet-ON Inducible Alpha-Synuclein Neuroblastoma Cell Line
      • SHSY5Y Tet-ON Inducible Alpha-Synuclein Neuroblastoma Cell Line
      • SH-Sy5y Tet-ON Inducible Alpha-Synuclein Neuroblastoma Cell Line
      • SY5Y Tet-ON Inducible Alpha-Synuclein Neuroblastoma Cell Line
      • SH-SY5Y Parental Tet-ON Inducible Alpha-Synuclein Neuroblastoma Cell Line
      Background InformationParkinson’s disease, the most common neurodegenerative movement disorder1, is caused by the progressive degeneration of dopaminergic neurons. A signature pathology of the brains of Parkinson’s patients is the buildup of misfolded aggregates of the protein α-synuclein.2 Aggregates of α-synuclein are also implicated in Lewy body dementia and Alzheimer’s disease.3 Although study of the complete pathogenesis of neurodegenerative diseases such as Parkinson’s requires animal models, cellular models that reflect distinct aspects of Parkinson’s pathology are of great value for understanding the multifaceted character of neurodegenerative diseases and useful for developing targeted treatments.

      The SHSY-5Y Tet-ON inducible α-synuclein neuroblastoma cell line serves as a model for both dopaminergic neuronal biology and α-synuclein pathology. SHSY-5Y cells may be induced upon treatment with retinoic acid to differentiate into neuronal-type cells, enabling studies of neuronal function and differentiation.4 SHSY-5Y cells secrete catecholamines and thus serve as a model for dopaminergic neurons. The SHSY-5Y TetON α-synuclein inducible cell line harbors an α-synuclein construct inducible by treatment with doxycycline, thus allowing controlled overexpression of α-synuclein before or after neuronal differentiation.5 The construct also includes a tet repressor, which prevents leaky expression in absence of inducer. This unique cell line is an excellent model for both the basic cellular physiology of Parkinson’s disease and therapeutic development.

      Source
      The SHSY-5Y Tet-ON Inducible -Synuclein cell line is stably transfected with a construct containing an alpha-synuclein cDNA cassette and CMV promoter under control of Tet-ON response element.5 The parental SHSY-5Y cell line was derived from a metastatic neuroblastoma of a 4-year-old female.6

      References
      1. Falkenburger BH, Saridaki T, Dinter E. J Neurochem 2016;139 (Suppl 1):121-130.
      2. Balestrino R, Schapira AHV. Eur J Neurol 2020; 27(1):27-42.
      3. Twohig D, Nielsen HM. Mol Neurodegener 2019; 14(1):23.
      4. Agholme L et al. J Alzheimer’s Dis 2010; 20(4):1069-1082.
      5. Vasquez V, Mitra J, Perry G, Rao KS, Hegde ML. J Alzheimers Dis 2018; 66(2):453-460.
      6. Biedler JL, Helson L, Spengler BA. Cancer Res 1973; 33(11):2643-2652.
      References
      Product Information
      Applications
      ApplicationSHSY-5Y Tet-ON inducible α-synuclein neuroblastoma cell line serves as a model for both dopaminergic neuronal biology and α-synuclein pathology.
      Key Applications
      • Cell Culture
      Application NotesThis product is intended for sale and sold solely to academic institutions for internal academic research use per the terms of the “Academic Use Agreement” as detailed in the product documentation. For information regarding any other use, please contact licensing@emdmillipore.com.
      Biological Information
      Cell Line Type
      • Cancer Cells
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Quality Assurance• Each vial contains ≥ 1X10⁶ viable cells.
      • SHSY-5Y Tet-ON Inducible -Synuclein Neuroblastoma cells are verified to be of human origin and negative for mouse, rat, Chinese hamster, Golden Syrian hamster, and non-human primate interspecies contamination, as assessed by a Contamination Clear panel by Charles River Animal Diagnostic Services
      • Cells tested negative for infectious diseases against a Human Essential CLEAR panel by Charles River Animal Diagnostic Services.
      • Cells tested negative for mycoplasma.
      Usage Statement
      • This product contains genetically modified organisms (GMO). Within the EU GMOs are regulated by Directives 2001/18/EC and 2009/41/EC of the European Parliament and of the Council and their national implementation in the member States respectively. This legislation obliges Merck to request certain information about you and the establishment where the GMOs are being handled. Click here for Enduser Declaration (EUD) Form.
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsThe cells should be stored in liquid nitrogen until use. The cells can be cultured for at least 10 passages after initial thawing without significantly affecting the cell marker expression and functionality.
      Packaging Information
      Material Size≥1X10⁶ cells/vial
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Catalogue Number GTIN
      SCC291 04065266024142